ArticleJournal of virology2026
Disruption of the S1/S2 multibasic cleavage site attenuates infectious bronchitis virus, while S2' partially restores viral virulence and expands tissue tropism.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Multibasic cleavage motifs play critical roles in envelope glycoprotein-mediated viral entry by serving as substrates for proprotein convertases like furin. The gamma-coronavirus infectious bronchitis virus (IBV) inherently possesses a conserved S1/S2 multibasic cleavage site (MBCS) within its S gene. Notably, the IBV Beaudette strain uniquely harbors an additional S2' MBCS, which extends its cellular tropism. Our previous work demonstrated that introducing the S2' MBCS into the YN strain contributes to central nervous system damage. However, the functional interplay between the S1/S2 and S2' MBCS has not yet been elucidated. Herein, we rescued several recombinant IBV mutants based on two different genotypes, engineered with distinct S protein cleavage patterns. Our results revealed that deletion of the S1/S2 MBCS results in a drastic reduction of viral replication efficiency and pathogenicity. This negative effect can be partially compensated by introducing the S2' MBCS. The S2' MBCS also rendered increased mortality and elevated viral loads in neurological organs-effects that were diminished with less efficient S1/S2 cleavage. Inconsistencies exist regarding the impact of MBCS mutations in different IBV strain backgrounds, which are mainly due to their differential dependence on host proteases, correlating with their distinct tissue tropism. Our study demonstrated a proteolytic coordination model for IBV S protein activation: The S1/S2 MBCS primarily confers efficient replication competence; the S2' site acts as an amplifier of organ-specific pathogenicity, particularly enhancing neurotropism. This synergistic relationship is conserved across different IBV strains. IMPORTANCE: Multibasic cleavage sites (MBCSs) are critical determinants of coronavirus pathogenicity and tissue tropism. While infectious bronchitis virus (IBV) inherently possesses a conserved S1/S2 cleavage site, the functional significance of this site and its potential interplay with the unique S2' MBCS found in the Beaudette strain remain poorly understood. Our study definitively establishes the critical role of the S1/S2 cleavage site for efficient IBV replication
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.